Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BI-2536 shows potential in models of osteosarcoma

Jan. 27, 2011

AMG-386 does not improve efficacy of CX combination in gastroesophageal adenocarcinoma

Jan. 27, 2011

Photocure reports final follow-up data from phase IIa study of Cevira

Jan. 26, 2011

GSK begins phase III trials of GSK-2118436 and GSK-1120212 in melanoma

Jan. 26, 2011

Takeda Bio begins Japanese portion of phase III AMG-386 trial

Jan. 26, 2011

Korean researchers develop (R)-bicalutamide prodrug

Jan. 26, 2011

Senesco Tech submits IND to FDA for SNS01-T in multiple myeloma

Jan. 26, 2011

Angion Biomedica patents new PARP-1 inhibitors

Jan. 26, 2011

AZD-0530 suppresses migration of biliary cancer cells in vitro

Jan. 26, 2011

New inhibitors claimed of lymphokine-activated killer T-cell-originated protein kinase

Jan. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...